EPO does not promote interaction between the erythropoietin and beta-common receptors.
Biophysical experiments did not detect a specific direct interaction between the extracellular EPOR and beta-common receptor domains, including in the presence of ARA-290.
Biophysical experiments did not detect a specific direct interaction between the extracellular EPOR and beta-common receptor domains, including in the presence of ARA-290.
Research summary
The authors assessed extracellular receptor-domain interactions using computational and in-vitro biophysical approaches, in the presence and absence of EPO or ARA-290. Their analysis did not support a specific direct association between the extracellular EPOR and beta-common receptor regions. Mouse anemia-stress experiments also did not show a requirement for the beta-common receptor.
Limitations and interpretation
This challenges a simplified direct receptor-complex explanation, but does not exclude every possible cellular signaling mechanism or invalidate all observed functional effects. It is basic mechanistic research, not a clinical efficacy trial. The innate-repair-receptor model should be presented as debated rather than as a settled molecular structure.
Source
Cheung Tung Shing KS, Broughton SE, Nero TL, et al. EPO does not promote interaction between the erythropoietin and beta-common receptors. Scientific reports. 2018 Aug 20. DOI: 10.1038/s41598-018-29865-x. PMID: 30127368.
Original PubMed record. Publisher DOI. Sources reviewed October 15, 2026. This page is an educational summary, not a reproduction of the full publication.
Connected compound
ARA-290 / cibinetide monograph. Educational information only; no treatment or personal-use recommendations.
Keywords
Research Goals
(2)For research use only. Not medical advice.